CalciMedica increases ATM facility maximum from $4.45M to $9.7M

CalciMedica, Inc.

Maximum aggregate offering price under ATM raised from $4.45M to $9.7M via prospectus supplement filed Nov 6, 2025.
Agreement with H.C. Wainwright dated Aug 11, 2023; prior supplement filed Dec 20, 2024.
Proceeds for general corporate purposes; potential dilution from additional share issuance under ATM.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.